BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 34289799)

  • 1. Health care resource utilization and treatment variability in the care of patients with advanced or metastatic colorectal or gastric cancer.
    Hess LM; Zhu YE; Fang Y; Liepa AM
    J Med Econ; 2021; 24(1):930-938. PubMed ID: 34289799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of heterogeneity in the first-line treatment of patients with advanced/metastatic gastric cancer in the U.S.
    Abrams T; Hess LM; Zhu YE; Schelman W; Liepa AM; Fuchs C
    Gastric Cancer; 2018 Sep; 21(5):738-744. PubMed ID: 29392573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between Eastern Cooperative Oncology Group performance status and healthcare resource utilization among patients with advanced or metastatic colorectal, lung or gastric cancer.
    Hess LM; Smith D; Cui ZL; Montejano L; Liepa AM; Schelman W; Bowman L
    J Drug Assess; 2020 Dec; 10(1):10-17. PubMed ID: 33403155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States.
    Zhang X; Beachler DC; Masters E; Liu F; Yang M; Dinh J; Jamal-Allial A; Kolitsopoulos F; Lamy FX
    J Manag Care Spec Pharm; 2022 Feb; 28(2):255-265. PubMed ID: 34854733
    [No Abstract]   [Full Text] [Related]  

  • 5. Health and resource burden of a cancer diagnosis on the caregiver: an analysis of administrative claims data.
    Hess LM; Wong-Jacobson SH; Peterson PM
    BMC Health Serv Res; 2021 Aug; 21(1):894. PubMed ID: 34461888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care resource utilization in the management of patients with Arginase 1 Deficiency in the US: a retrospective, observational, claims database study.
    Bin Sawad A; Jackimiec J; Bechter M; Hull M; Yeaw J; Wang Y; Diaz GA
    J Med Econ; 2022; 25(1):848-856. PubMed ID: 35695271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare costs and resource utilization in patients with severe aplastic anemia in the US.
    Cai B; Said Q; Li X; Li FY; Arcona S
    J Med Econ; 2019 Oct; 22(10):1055-1062. PubMed ID: 31296074
    [No Abstract]   [Full Text] [Related]  

  • 8. Healthcare resource use and direct costs in severe aplastic anemia (SAA) patients before and after treatment with eltrombopag.
    Cai B; Said Q; Li X; Li FY; Arcona S
    J Med Econ; 2020 Mar; 23(3):243-251. PubMed ID: 31686551
    [No Abstract]   [Full Text] [Related]  

  • 9. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).
    McArthur GA; Mohr P; Ascierto PA; Arance A; Banos Hernaez A; Kaskel P; Weichenthal M; Shinde R; Stevinson K
    Oncologist; 2017 Aug; 22(8):951-962. PubMed ID: 28526721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization.
    Chastek B; Kulakodlu M; Valluri S; Seal B
    Postgrad Med; 2013 Mar; 125(2):73-82. PubMed ID: 23816773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA.
    Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
    Adv Ther; 2020 Jun; 37(6):2777-2791. PubMed ID: 32399813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer.
    Gómez-Ulloa D; Amonkar M; Kothari S; Cheung WY; Chau I; Zalcberg JR; Lara Suriñach N; Falcone A
    BMC Gastroenterol; 2020 May; 20(1):133. PubMed ID: 32370803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study.
    Lee DH; Isobe H; Wirtz H; Aleixo SB; Parente P; de Marinis F; Huang M; Arunachalam A; Kothari S; Cao X; Donnini N; Woodgate AM; de Castro J
    BMC Health Serv Res; 2018 Mar; 18(1):147. PubMed ID: 29490654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
    Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
    Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus.
    Lokhandwala T; Coutinho AD; Bell CF
    Clin Ther; 2021 Aug; 43(8):1320-1335. PubMed ID: 34243966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United States.
    Samuelsen C; Lim J; Golembesky A; Shrestha S; Wang L; Griebsch I
    J Med Econ; 2020 Jan; 23(1):48-53. PubMed ID: 31314630
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France.
    Grumberg V; Chouaïd C; Cotté FE; Jouaneton B; Jolivel R; Gaudin AF; Reynaud D; Assié JB; Borget I
    J Med Econ; 2022; 25(1):691-699. PubMed ID: 35587018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs.
    Dignass A; Waller J; Cappelleri JC; Modesto I; Kisser A; Dietz L; DiBonaventura M; Wood R; May M; Libutzki B; Bargo D
    J Med Econ; 2020 Apr; 23(4):415-427. PubMed ID: 31858853
    [No Abstract]   [Full Text] [Related]  

  • 19. Healthcare resource utilization and costs among children with cystic fibrosis in the United States.
    Thorat T; McGarry LJ; Bonafede MM; Limone BL; Rubin JL; Jariwala-Parikh K; Konstan MW
    Pediatr Pulmonol; 2021 Sep; 56(9):2833-2844. PubMed ID: 34138523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare utilization and costs for patients initiating Dabigatran or Warfarin.
    Reynolds SL; Ghate SR; Sheer R; Gandhi PK; Moretz C; Wang C; Sander S; Costantino ME; Annavarapu S; Andrews G
    Health Qual Life Outcomes; 2017 Jun; 15(1):128. PubMed ID: 28637460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.